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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S228degradation and bone resorption, but did not reduce WOMAC symp-
toms or joint space narrowing over 2 years. Zoledronic acid reduced
knee pain and size of BML over 6 months. Overall, studies assessed
different medications, doses, endpoints and duration of observation;
the longest duration of observation in a clinical trial was 2 years.
Purpose: To investigate the effect of bisphosphonate use on symptoms
and structural progression of knee OA over four years of observation in
participants from the NIH Osteoarthritis Initiative
Methods: OAI participants with typical knee OA trial entry criteria (KL2/
3, minimum joint space width (mJSW) 2.5-5.0mm and pain 4 on
a numerical rating scale [NRS]) were classiﬁed as bisphosphonate users
(3 of the 5 years; n¼55) or non-users (no use in the preceding 5 years
or during follow-up; n¼268). Outcomes were pain (NRS, WOMAC),
WOMAC disability and stiffness, joint space narrowing (JSN), proportion
reporting radiological and radioclinical progression, and joint replace-
ment. Annual data over 4 years were analysed using linear mixed
modelling and generalised estimating equations, after adjustment for
age, BMI, and baseline pain where appropriate.
Results: Study patients were older women with knee OA, mean age
618.4 years (range 45-79), mean BMI 31.45.5 (range 18.8 - 48.7).
Bisphosphonate users were older, shorter, thinner, less physically active,
and more likely to be white than non-users. Bisphosphonate compli-
ance was 85% at year 1, reducing to 76% by year 4. Alendronate was the
most common bisphosphonate used (60-70%). NRS pain scores were
signiﬁcantly reduced among bisphosphonate users at years 2 and 3
(Year 3, -0.9 vs -2.2, p¼0.004), though not year 4, after adjustment for
baseline pain and analgesic use. Differences in WOMAC pain and
disability scores did not reach statistical signiﬁcance at any time point.
There was a trend to less JSN in bisphosphonate users over time (Year 4,
0.51mm vs 0.29mm; p¼0.06). Radiological progression (0.5 mm) was
reduced at year 3 (82% vs 11%, p¼0.041). Differences in rates of knee
replacement were not signiﬁcant.
Conclusions: We demonstrate reduction in pain intensity (NRS),
radiological progression and a trend to less JSN in bisphosphonate users
compared to non-users. Signiﬁcant reduction in NRS pain was observed
in the ﬁrst 3 years; diminution of effects by year 4 may reﬂect reduced
compliance, suggesting beneﬁcial effects may discontinue following
medication cessation. Differences in results obtained using NRS and
WOMAC may reﬂect different constructs measured by these tools. The
beneﬁcial trend on structural progression should be considered in
terms of the sample size.
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QUANTITATIVE 3D ANALYSIS OF CARTILAGE LESIONS AND
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MICRO-CT IMAGING IN COMPARISON WITH HISTOPATHOLOGY
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Kamath z, R.E. Guldberg y. yGeorgia Inst. of Technology, Atlanta, GA,
USA; zAbbott Lab., Worcester, MA, USA
Purpose: Development and characterization of small animal models
of osteoarthritis (OA) is an important for a better understanding of
OA pathogenesis and to evaluate disease modifying OA drugs
(DMOADs). A common surgical method of inducing OA involves
transecting the medial meniscus (MMT). The traditional method to
detect changes in articular cartilage is via histopathology which is
a time consuming and semi-quantitative process. Equilibrium Parti-
tioning of an Ionic Contrast Agent based micro-CT (EPIC-mCT) imaging
has recently been developed to characterize and quantify changes in
the articular cartilage. Objective: Quantify articular cartilage changes
as a function of time following MMT surgery and compare results
with independent histopathology data. Hypothesis: EPIC-mCT has the
sensitivity to detect and quantify articular cartilage damage and
osteophyte development
Methods: Animal model: Weight-matched male Lewis rats (275-300g)
underwent MMT on the right leg (n¼18) or sham surgery (n¼18) and
were sacriﬁced at 1, 2 and 3 weeks. m-CT Imaging: Joints were dissected
and scanned using a mCT 40 following equilibration in Hexabrix contrast
agent. Images were evaluated for 3 volumes of interest (VOIs): (1)
Medial 1/3 of medial tibial plateau (2) Only focal lesions on the medial
plateau (3) Only osteophytes (width > 200mm). Cartilage attenuation,
a quantitative metric inversely related to proteoglycan content was also
established. Focal defects were deﬁned as: erosions (defect < 50% of
thickness) or lesions (defect > 50% of thickness) (Fig 1) (All surgeries
were performed at Abbott Laboratories and approved by IACUC).Figure 1. Representative images of focal defects and osteophyte (OP) character-
ization.Histology: Histology was performed on the same samples after
decalciﬁcation, stained with Toluidine blue and scores were assigned by
a histopathologist. Statistics: Data are reported as mean  SEM and
analyzed with t-tests or one way ANOVA.
Results: Cartilage attenuation following MMT was signiﬁcantly
higher at week 2 and 3 compared to controls indicating lower
proteoglycan content (Fig 2). Similarly, histopathology scoring
showed a higher cartilage degradation score at week 2 and 3
compared to day 3 (Fig 2). Lesions were detected and quantiﬁed in
the MMT animals at week 2 and 3 with the maximum lesion volume
being observed in the MMT animals at week 3 (Fig 2). Areas of
erosion were evident one week post surgery; however lesions did not
begin to develop until week 2. There was a signiﬁcant increase in the
number and volume of lesions between weeks 2 and 3. Osteophyte:
Average peripheral thickness increased with time, consistent with 2D
histopathology data (Fig 3). Total peripheral volume, mineralized
peripheral volume and average 3D peripheral thickness were greater
for MMT animals compared to controls at weeks 2 and 3 (Fig 3).
Representative images show osteophytes both in histology and
micro-CT (Fig 3).
Figure 2. Comparision of histo-pathology data with CT data.Ă
Figure 3. Quantiﬁcation of osteophyte parameters.Ă
Conclusions: This study successfully demonstrates that progression of
joint degeneration can be detected by EPIC-mCT over the period of 3
weeks in the MMT model. Additionally, this is the ﬁrst instance of
quantiﬁcation of osteophyte development and mineralization in the
MMT model. Differences in osteophyte thickness and volume were
detected as early as 2 weeks via EPIC-mCT which could not be identiﬁed
via histology. At 3 weeks, EPIC-mCT data replicated 2D histopathology
data with the advantage of providing more detailed and quantitative
data while requiring fewer animals.
